Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TESS study
2017-000447-40Phase 3Terminated
- Sponsor
- ASST Santi Paolo e Carlo
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of darunavir, ritonavir, maraviroc and lamivudine in human immunodeficiency virus infection (HIV) and osteopenia (2 arms), sponsored by ASST Santi Paolo e Carlo. Primary endpoint: Change in bone mineral density at spine or femur. Started Nov 2020; status: terminated.
02
Drugs
darunavirritonavirmaraviroclamivudine
03
Conditions
human immunodeficiency virus infection (HIV)osteopenia
Beyond the preview
Go deeper on 2017-000447-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000447-40.